Thiogenesis Therapeutics Corp. (TTI V) stock market data APIs
C$0.5955
-0.02(-3.4%)
as of May 29, 2026
Try our APIs with
free plan!
Thiogenesis Therapeutics Corp. Financial Data Overview
Price chart is built with
Anychart
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.
Prev. Close
0.5955
Open
0.5723
High
0.5998
Low
0.5681
52 wk Range
0.44-0.88
Market Cap
31 102 K
Shares Outstanding
51 836 K
Beta
0.525
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Thiogenesis Therapeutics Corp. data using free add-ons & libraries
Get Thiogenesis Therapeutics Corp. Fundamental Data
Thiogenesis Therapeutics Corp. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Thiogenesis Therapeutics Corp. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-06-02
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Thiogenesis Therapeutics Corp. News
New
kneat.com Spotlights ARR Surge to CAD 74M, New Strategic Customers and AI Rollout at Conference
kneat.com logo Key Points Kneat reported ARR growth from CAD 15 million four years ago to CAD 74 million today with net recurring revenue at 115%, added multiple strategic customers and says enterpr...
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics
Company Logo Leigh syndrome is a severe, rare neurological disorder primarily affecting infants, characterized by progressive motor skill loss and respiratory failure, often leading to death. The gro...
Get Thiogenesis Therapeutics Corp. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
